PDS Biotech Provides Clinical Programs Update and Reports Third Quarter 2024 Financial Results
In October 2024, we provided updated results from our IMMUNOCERV Phase 2 clinical trial in locally advanced cervical cancer patients treated with Versamune ® HPV and chemoradiotherapy presented at the ...
Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference
A live audio webcast of the presentation can be accessed through the Investors section of the Company’s website at www.mereobiopharma.com/investors. An archived replay of the webcast will be available ...